Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell membrane anionic phospholipids, primarily phosphatidylglycerol (PG) and cardiolipin (CL), are essential components of the bacterial cytoplasmic membrane that provide a net negative surface charge (Dowhan, W., 1997, Annu. Rev. Biochem.). This negative charge is a critical discriminator between bacterial and mammalian cells, as the latter's outer leaflets are primarily composed of zwitterionic lipids like phosphatidylcholine (Yeaman, M.R. & Yount, N.Y., 2003, Pharmacol. Rev.). These phospholipids play vital roles in maintaining membrane integrity, anchoring proteins, and coordinating cell wall biosynthesis (Epand, R.M. et al., 2016, Biochim. Biophys. Acta). They serve as the primary target for several classes of antibiotics, including lipopeptides like daptomycin, which binds to PG in a calcium-dependent manner to cause membrane depolarization (Müller, A. et al., 2016, PNAS). Additionally, polymyxins interact with these anionic lipids to disrupt the membrane barrier in Gram-negative bacteria (Velkov, T. et al., 2013, J. Med. Chem.). Targeting these lipids is a highly effective strategy for treating multi-drug resistant infections, though it requires careful management of potential toxicities such as myopathy or nephrotoxicity (Bari, A.K. et al., 2022, Cureus).
Binding to anionic phospholipids leads to membrane permeabilization, loss of membrane potential (depolarization), and leakage of intracellular ions, resulting in rapid cell death.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane anionic phospholipid.